0001179110-20-003834.txt : 20200317
0001179110-20-003834.hdr.sgml : 20200317
20200317172238
ACCESSION NUMBER: 0001179110-20-003834
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200313
FILED AS OF DATE: 20200317
DATE AS OF CHANGE: 20200317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rizvi Qasim
CENTRAL INDEX KEY: 0001794636
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 20722093
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS CORP.
STREET 2: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
edgar.xml
FORM 4 -
X0306
4
2020-03-13
0
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001794636
Rizvi Qasim
CLARENDON HOUSE
2 CHURCH STREET
HAMILTON
D0
HM 11
BERMUDA
0
1
0
0
Chief Commercial Officer
Share Option
15.52
2020-03-13
4
A
0
75000
0
A
2030-03-12
Class A Common Shares
75000
75000
D
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is March 13, 2020.
/s/ Thomas W. Beetham, Attorney-in-Fact For Qasim Rizvi
2020-03-17